Close Menu

NEW YORK (GenomeWeb) – Illumina has filed a lawsuit against Ariosa Diagnostics and its parent firm, Roche Molecular Systems, for allegedly infringing one of its patents.

Illumina filed its suit Monday in the US District Court for the Northern District of California alleging that Ariosa is infringing its US Patent No. 7,955,794, entitled "Multiplex Nucleic Acid Reactions." Specifically, Illumina believes that Ariosa's microarray-based version of its Harmony Prenatal Test is infringing that patent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.

Mar
17
Sponsored by
IONPath

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.